Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 11;15(8):2244.
doi: 10.3390/cancers15082244.

Innovative Invasive Loco-Regional Techniques for the Treatment of Lung Cancer

Erik Claes  1   2 , Reinier Wener  3 , Arne P Neyrinck  2   4 , Axelle Coppens  1   2 , Paul E Van Schil  1   2 , Annelies Janssens  5 , Thérèse S Lapperre  3   6 , Annemiek Snoeckx  7   8 , Wen Wen  2 , Hanne Voet  3   6 , Stijn E Verleden  1   2   3 , Jeroen M H Hendriks  1   2
Affiliations
Review

Innovative Invasive Loco-Regional Techniques for the Treatment of Lung Cancer

Erik Claes et al. Cancers (Basel). .

Abstract

Surgical resection is still the standard treatment for early-stage lung cancer. A multimodal treatment consisting of chemotherapy, radiotherapy and/or immunotherapy is advised for more advanced disease stages (stages IIb, III and IV). The role of surgery in these stages is limited to very specific indications. Regional treatment techniques are being introduced at a high speed because of improved technology and their possible advantages over traditional surgery. This review includes an overview of established and promising innovative invasive loco-regional techniques stratified based on the route of administration, including endobronchial, endovascular and transthoracic routes, a discussion of the results for each method, and an overview of their implementation and effectiveness.

Keywords: endobronchial; endovascular; inhalation; lung cancer; regional perfusion; transthoracic.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Overview of the loco-regional techniques based on their route of administration.
See this image and copyright information in PMC

References

    1. Sung H., Ferlay J., Siegel R.L., Laversanne M., Soerjomataram I., Jemal A., Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2021;71:209–249. doi: 10.3322/caac.21660. - DOI - PubMed
    1. Ganti A.K., Klein A.B., Cotarla I., Seal B., Chou E. Update of Incidence, Prevalence, Survival, and Initial Treatment in Patients With Non–Small Cell Lung Cancer in the US. JAMA Oncol. 2021;7:1824–1832. doi: 10.1001/jamaoncol.2021.4932. - DOI - PMC - PubMed
    1. Dingemans A.C., Früh M., Ardizzoni A., Besse B., Faivre-Finn C., Hendriks L.E., Lantuejoul S., Peters S., Reguart N., Rudin C.M., et al. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆) Ann. Oncol. 2021;32:839–853. doi: 10.1016/j.annonc.2021.03.207. - DOI - PMC - PubMed
    1. Planchard D., Popat S., Kerr K., Novello S., Smit E.F., Faivre-Finn C., Mok T.S., Reck M., Van Schil P.E., Hellmann M.D., et al. Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2018;29:iv192–iv237. doi: 10.1093/annonc/mdy275. - DOI - PubMed
    1. Remon J., Soria J.C., Peters S. Early and locally advanced non-small-cell lung cancer: An update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy. Ann. Oncol. 2021;32:1637–1642. doi: 10.1016/j.annonc.2021.08.1994. - DOI - PubMed

LinkOut - more resources